Overexpression of testes-specific protease 50 (TSP50) predicts poor prognosis in patients with gastric cancer

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Liu, Fang ^a   Cao, Qinghua ^b   Liu, Ni ^b   Li, Changzhao ^c   You, Changxuan ^a   Liu, Chuanxin ^a   Xue, Ling ^b   Luo, Rongcheng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE; TESTES SPECIFIC PROTEASE 50; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH SURGERY; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 84899513798     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/498246     Document Type: Article

References (37)

1. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002. Ca: A Cancer Journal for Clinicians 2005 55 2 74 108 2-s2.0-14944385553
2. Yang L., Incidence and mortality of gastric cancer in China. World Journal of Gastroenterology 2006 12 1 17 20 2-s2.0-31144445320
3. Albarello L., Pecciarini L., Doglioni C., HER2 testing in gastric cancer. Advances in Anatomic Pathology 2011 18 1 53 59 2-s2.0-78650783838 10.1097/PAP.0b013e3182026d72
4. Xing X., Tang Y. B., Yuan G., The prognostic value of E-cadherin in gastric cancer: a meta-analysis. International Journal of Cancer 2013 132 11 2589 2596
5. Nam K. H., Lee B. L., Park J. H., Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology 2013 80 87 94
6. Yuan L., Shan J., De Risi D., Broome J., Lovecchio J., Gal D., Vinciguerra V., Hao-Peng X., Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer. Cancer Research 1999 59 13 3215 3221 2-s2.0-0033168044
7. Shan J., Yuan L., Xiao Q., Chiorazzi N., Budman D., Teichberg S., Xu H. P., TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells. Cancer Research 2002 62 1 290 294 2-s2.0-0036144601
8. Ogata K., Aihara R., Mochiki E., Ogawa A., Yanai M., Toyomasu Y., Ando H., Ohno T., Asao T., Kuwano H., Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer. Annals of Surgical Oncology 2011 18 4 1195 1203 2-s2.0-79955819316 10.1245/s10434-010-1399-z
9. Kim Y., Jeoung D., Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility. Journal of Microbiology and Biotechnology 2008 18 3 600 610 2-s2.0-46749090951
10. Nakamura Y., Tanaka F., Nagahara H., Ieta K., Haraguchi N., Mimori K., Sasaki A., Inoue H., Yanaga K., Mori M., Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer. Annals of Surgical Oncology 2007 14 2 885 892 2-s2.0-33846601794 10.1245/s10434-006-9121-x
11. Kononen J., Bubendorf L., Kallioniemi A., Bärlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M. J., Sauter G., Kallioniemi O.-P., Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine 1998 4 7 844 847 2-s2.0-0031822837 10.1038/nm0798-844
12. Wu X. Y., Chen J., Cao Q. H., Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma. Tumor Biology 2013 34 2 713 722 10.1007/s13277-012-0599-5
13. Japanese classification of Gastric Carcinoma. Gastric Cancer 1998 1 1 10 24 10.1007/PL00011681
14. Xu H., Shan J., Jurukovski V., Yuan L., Li J., Tian K., TSP50 encodes a testis-specific protease and is negatively regulated by p53. Cancer Research 2007 67 3 1239 1245 2-s2.0-33847069272 10.1158/0008-5472.CAN-06-3688
15. Song Z. B., Bao Y. L., Zhang Y., Mi X. G., Wu P., Wu Y., Yu C. L., Sun Y., Zheng L. H., Huang Y. X., Liu B., Li Y. X., Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the nuclear factor B (NF- B) signalling pathway. Biochemical Journal 2011 436 2 457 467 2-s2.0-79955987554 10.1042/BJ20101780
16. Zheng L., Xie G., Duan G., Yan X., Li Q., High expression of Testes-Specific protease 50 is associated with poor prognosis in colorectal carcinoma. PLoS ONE 2011 6 7 2-s2.0-79960158467 10.1371/journal.pone.0022203 e22203
17. Chen Y. T., Scanlan M. J., Sahin U., Türeci Ö., Gure A. O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L. J., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proceedings of the National Academy of Sciences of the United States of America 1997 94 5 1914 1918 2-s2.0-12644276375 10.1073/pnas.94.5.1914
18. Fratta E., Coral S., Covre A., Parisi G., Colizzi F., Danielli R., Marie Nicolay H. J., Sigalotti L., Maio M., The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Molecular Oncology 2011 5 2 164 182 2-s2.0-79955475321 10.1016/j.molonc.2011.02.001
19. Cheng Y. H., Wong E. W., Cheng C. Y., Cancer/testis, (CT) antigens, carcinogenesis and spermatogenesis. Spermatogenesis 2011 1 3 209 220 10.4161/spmg.1.3.17990
20. Bertram J., Palfner K., Hiddemann W., Kneba M., Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription- polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anti-Cancer Drugs 1998 9 4 311 317 2-s2.0-0031800720
21. Laduron S., Deplus R., Zhou S., Kholmanskikh O., Godelaine D., de Smet C., Hayward S. D., Fuks F., Boon T., De Plaen E., MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Research 2004 32 14 4340 4350 2-s2.0-4544302621 10.1093/nar/gkh735
22. Shim H., Lee H., Jeoung D., Cancer/testis antigen cancer-associated gene (CAGE) promotes motility of cancer cells through activation of focal adhesion kinase (FAK). Biotechnology Letters 2006 28 24 2057 2063 2-s2.0-33845312612 10.1007/s10529-006-9190-8
23. Cilensek Z. M., Yehiely F., Kular R. K., Deiss L. P., A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, interferon- γ taxol and γ -irradiation. Cancer Biology and Therapy 2002 1 4 380 387 2-s2.0-0038495255 10.4161/cbt.1.4.12
24. Zhou L., Bao Y. L., Zhang Y., Wu Y., Yu C. L., Huang Y. X., Sun Y., Zheng L. H., Li Y. X., Knockdown of TSP50 inhibits cell proliferation and induces apoptosis in P19 cells. IUBMB Life 2010 62 11 825 832 2-s2.0-79952022730 10.1002/iub.390
25. Li Y. Y., Bao Y. L., Song Z. B., Sun L. G., Wu P., Zhang Y., Fan C., Huang Y. X., Wu Y., Yu C. L., Sun Y., Zheng L. H., Wang G. N., Li Y. X., The threonine protease activity of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation. PLoS ONE 2012 7 5 2-s2.0-84860521722 10.1371/journal.pone.0035030 e35030
26. Matsuda R., Enokida H., Chiyomaru T., Kikkawa N., Sugimoto T., Kawakami K., Tatarano S., Yoshino H., Toki K., Uchida Y., Kawahara K., Nishiyama K., Seki N., Nakagawa M., LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling. British Journal of Cancer 2011 104 2 376 386 2-s2.0-78751569524 10.1038/sj.bjc.6605990
27. Li F., Liu Q., Han Y., Sperm protein 17 is highly expressed in endometrial and cervical cancers. BMC Cancer 2010 10, article 429 10.1186/1471-2407-10-429
28. de Smet C., de Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T., The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proceedings of the National Academy of Sciences of the United States of America 1996 93 14 7149 7153 2-s2.0-0029957792 10.1073/pnas.93.14.7149
29. Szyf M., The role of DNA hypermethylation and demethylation in cancer and cancer therapy. Current Oncology 2008 15 2 72 75 2-s2.0-53349163022
30. Feinberg A. P., Vogelstein B., Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983 301 5895 89 92 2-s2.0-0020699979
31. Shin C. M., Kim N., Park J. H., Kang G. H., Kim J. S., Jung H. C., Song I. S., Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae. Journal of Pathology 2012 226 4 654 665 2-s2.0-84856755166 10.1002/path.2990
32. Park J. H., Park J., Choi J. K., Identification of DNA methylation changes associated with human gastric cancer. BMC Medical Genomics 2011 4, article 82 10.1186/1755-8794-4-82
33. Simpson A. J., Caballero O. L., Jungbluth A., Chen Y. T., Old L. J., Cancer/testis antigens, gametogenesis and cancer. Nature Reviews Cancer 2005 5 8 615 625 2-s2.0-23144464171 10.1038/nrc1669
34. Siliņa K., Zayakin P., Kalniņa Z., Ivanova L., Meistere I., Endzeliņš E., Abols A., Stengrevics A., Leja M., Ducena K., Kozirovskis V., Line A., Sperm-associated antigens as targets for cancer immunotherapy: Expression pattern and humoral immune response in cancer patients. Journal of Immunotherapy 2011 34 1 28 44 2-s2.0-78650647189 10.1097/CJI.0b013e3181fb64fa
35. Demento S. L., Siefert A. L., Bandyopadhyay A., Sharp F. A., Fahmy T. M., Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends in Biotechnology 2011 29 6 294 306 2-s2.0-79956114010 10.1016/j.tibtech.2011.02.004
36. Marchand M., Van Baren, Boon T., Tumor regression observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. International Journal of Cancer 1999 80 2 219 230
37. Kawada J., Wada H., Isobe M., Gnjatic S., Nishikawa H., Jungbluth A. A., Okazaki N., Uenaka A., Nakamura Y., Fujiwara S., Mizuno N., Saika T., Ritter E., Yamasaki M., Miyata H., Ritter G., Murphy R., Venhaus R., Pan L., Old L. J., Doki Y., Nakayama E., Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination. International Journal of Cancer 2012 130 3 584 592 2-s2.0-82255191897 10.1002/ijc.26074